FDA approves two drugs, companion diagnostic test for advanced skin cancer

FDA approves two drugs, companion diagnostic test for advanced skin cancer

FDA approves two drugs, companion diagnostic test for advanced skin cancer. The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable

9
Like
Save

Comments

Write a comment

*